As the world leader in digital medication adherence monitoring for successful clinical trials, AARDEX is proud to announce its collaboration with 4 Belgian/Swiss financial partners to assist company’s growth.

SRIW, Sowalfin, Noshaq and CCF (Centre de Cautionnement et de Financement du Valais) are now part of the AARDEX Adventure.

Back to news
Further information and contact
Contact Us
Recent Post

How the EMERGE guideline on medication adherence can improve the quality of clinical trials

By szuferrey | March 25, 2020

As the world leader in digital medication adherence monitoring for successful clinical trials, AARDEX is proud to announce its collaboration with 4 Belgian/Swiss financial partners to assist company’s growth.

By szuferrey | March 6, 2020

AARDEX’s scientific lead Bernard Vrijens is a panelist of the FDA and Duke-Margolis public meeting to explore the state of the science of clinical research evaluating medication adherence on December 10, 2019

By aardexwp | December 12, 2019

AARDEX is collaborating with Pfizer to implement MEMS® in the FORWARD National Databank for Rheumatic Diseases to derive real world evidence adherence data.

By aardexwp | November 19, 2019

Important milestone in managing adherence to anti-osteoporosis treatment

By aardexwp | October 29, 2019